Search
Quince Therapeutics Inc
QNCXAdd to Watchlist
29.360USD
+2.640+9.88%
Close 10-08 16:00（ET）
28.77MMarket Cap
1.30P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+9.88%
5 Days
-4.30%
1 Month
-0.47%
6 Months
-19.78%
Year to Date
-95.62%
1 Year
-92.35%
Key Figures
27.095Open
29.800High
4.67KVolume
1.30P/E TTM
LossP/E Dynamic
--Dividend TTM
0.48%Turnover Ratio
26.720Prev. Close
26.650Low
130.75KTurnover
LossP/E Static
-0.81P/B
0.00%Div Yield TTM
-49.42%ROA
35.41052wk High
0.16Volume Ratio
-56.83MNet Profit
980.00KShares
22.6572EPS TTM
1.42Beta
-192.90%ROE
16.00052wk Low
10.25%Amplitude
--Gross Margin
28.77MMarket Cap
6.69Reward/Risk
134.19%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Quince Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-12.31/-17.88
Revenue / Forecast
--/0.00
Quince Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolQNCX
Number of employees36
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Lamond (David A.) | 2.69% |
| Nantahala Capital Management, LLC | 1.64% |
| Adage Capital Management, L.P. | 1.38% |
| Woodline Partners LP | 1.19% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 5.90% |
| Individual Investor | 3.19% |
| Investment Advisor | 2.89% |
| Investment Advisor/Hedge Fund | 1.48% |
Related Instruments
-1.61%
-0.76%
+0.39%
-0.29%
-0.12%
-0.84%
-1.37%
+0.17%
-0.21%
-0.64%
-0.47%
-0.20%
+2.19%
+0.07%
-1.02%
+0.26%
-0.34%
+0.82%
+2.93%
-11.83%Popular Instruments
51253.700
+16.300 (+0.03%)
30920.100
+140.400 (+0.46%)
7784.200
+13.800 (+0.18%)
13775.000
+119.000 (+0.87%)
69092.000
+881.000 (+1.29%)
6162.400
+7.900 (+0.13%)
89.842
-0.342 (-0.38%)
340.420
+3.750 (+1.11%)
230.480
-6.990 (-2.94%)
4190.560
+58.130 (+1.41%)
FAQs
What is the current price of Quince Therapeutics Inc (QNCX)?
The current price of Quince Therapeutics Inc (QNCX) is 29.36.
What is the symbol of Quince Therapeutics Inc?
The ticker symbol of Quince Therapeutics Inc is QNCX.
What is the 52-week high of Quince Therapeutics Inc?
The 52-week high of Quince Therapeutics Inc is 35.41.
What is the 52-week low of Quince Therapeutics Inc?
The 52-week low of Quince Therapeutics Inc is 16.00.
What is the market capitalization of Quince Therapeutics Inc?
The market capitalization of Quince Therapeutics Inc is 28.77M.
Is Quince Therapeutics Inc (QNCX) currently rated as Buy, Hold, or Sell?
According to analysts, Quince Therapeutics Inc (QNCX) has an overall rating of Buy, with a price target of 75.43.
What is the Earnings Per Share (EPS TTM) of Quince Therapeutics Inc (QNCX)?
The Earnings Per Share (EPS TTM) of Quince Therapeutics Inc (QNCX) is 22.66.